Proactive Investors - Run By Investors For Investors

Mediclinic downgraded to 'neutral' by JP Morgan Cazenove

There were some positive signs in yesterday's trading update in that the Abu Dhabi business appears to be recovering, but ...
Patient healthcare
The main concern for the private healthcare provider is Switzerland

There are signs of light in the desert but clouds are gathering in the mountains, said JP Morgan Cazenove, waxing lyrical about Mediclinic International Plc (LON:MDC).

The clouds in the (Swiss) mountains are evidently blocking out the sun in the (UAE) desert, because Cazenove downgraded the private healthcare provider to “neutral” from “overweight”.

The price target has been slashed from 898p to 733p.

The broker said Mediclinic’s half-year (H1) statement was “again disappointing”.

The United Arab Emirates (UAE) business might be recovering but the Swiss and Southern African operations appear to be under greater pressure.

Cazenove expects the current financial year to be tough and next year will probably be tough as well, and there are few near-term share price catalysts.

“Nonetheless the assets are well invested and in our view there is fat in the business, creating options. We continue to see longer-term value and believe MDC is oversold but uncertainties remain and investor patience will likely be required,” the broker suggested.

View full MDC profile View Profile

Mediclinic International Plc Timeline

Related Articles

Pictured is the company's myLotus test
May 15 2019
Here we take a closer look at testing firm Concepta PLC (LON:CPT)
An illustration of Ozop's BLIF technique
March 30 2019
A key area of focus for the West Palm Beach, Florida, company is development of balloon lumbar interbody fusion (BLIF) technology
cancer cell
Wed
The San Diego-based company has developed a patented liquid biopsy technology called Target Selector the detects and isolates cancer biomarkers such as circulating tumor cells (CTCs) and cell-free circulating tumor DNA (ctDNA)

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use